Regeneron Pharmaceuticals' Change in Inventory fell 10178.42% to -$2.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $275.3 million, marking a year-over-year decrease of 5557.53%. This contributed to the annual value of $275.3 million for FY2025, which is 5557.53% down from last year.
Latest data reveals that Regeneron Pharmaceuticals reported Change in Inventory of -$2.1 million as of Q4 2025, which was down 10178.42% from $82.6 million recorded in Q3 2025.
Regeneron Pharmaceuticals' Change in Inventory's 5-year high stood at $252.8 million during Q1 2021, with a 5-year trough of -$31.3 million in Q2 2021.
For the 5-year period, Regeneron Pharmaceuticals' Change in Inventory averaged around $117.9 million, with its median value being $113.4 million (2021).
Per our database at Business Quant, Regeneron Pharmaceuticals' Change in Inventory tumbled by 11924.97% in 2021 and then surged by 86709.27% in 2022.
Quarter analysis of 5 years shows Regeneron Pharmaceuticals' Change in Inventory stood at $163.7 million in 2021, then dropped by 11.85% to $144.3 million in 2022, then tumbled by 67.22% to $47.3 million in 2023, then skyrocketed by 148.84% to $117.7 million in 2024, then plummeted by 101.78% to -$2.1 million in 2025.
Its last three reported values are -$2.1 million in Q4 2025, $82.6 million for Q3 2025, and $42.5 million during Q2 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value